EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Development of a new minimally invasive phototherapy for lung cancer using antibody–toxin conjugate

Takumi Sonokawa iD, Naoko Obi, Jitsuo Usuda, Yukio Sudo, Takao Hamakubo

Thoracic Cancer · 2023-03 · 14 (7) · 645-653

DOI: 10.1111/1759-7714.14776 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Thoracic Cancer, online erschienen am 19.01.2023. Verfasst von Takumi Sonokawa und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery, Nippon Medical School, Tokyo, Japan. Hauptthemen laut MEDLINE: Photochemotherapy, Immunotoxins, Lung Neoplasms. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Photodynamic therapy (PDT) is a cancer‐targeted treatment that uses a photosensitizer (PS) and laser irradiation. The effectiveness of current PDT using red light for advanced cancers is limited, because red light can only reach depths within a few millimeters. To enhance the antitumor effect for lung cancers, we developed a new phototherapy, intelligent targeted antibody phototherapy (iTAP). This treatment uses a combination of immunotoxin and a PS, mono‐L‐aspartyl chlorin e6 (NPe6).

Methods

We examined whether cetuximab encapsulated in endosomes was released into the cytosol by PS in PDT under light irradiation. A431 cells were treated with fluorescein isothiocyanate‐labeled cetuximab, NPe6, and light irradiation and were observed with fluorescence microscopy. We analyzed the cytotoxicity of saporin‐conjugated cetuximab (IT‐cetuximab) in A431, A549, and MCF7 cells and the antitumor effect in model A549‐bearing mice in vivo using the iTAP method.

Results

Fluorescent microscopy analysis showed that the photodynamic effect of NPe6 (20 μM) and light irradiation (37.6 J/cm 2 ) caused the release of cetuximab from the endosome into the cytosol. In vitro analysis demonstrated that the iTAP method enhanced the cytotoxicity of IT‐cetuximab by the photodynamic effect. In in vivo experiments, compared with IT‐cetuximab alone or PDT alone, the iTAP method using a low dose of IT‐cetuximab showed the greatest enhancement of the antitumor effect.

Conclusions

Our study is the first report of the iTAP method using NPe6 for lung cancer cells. The iTAP method may become a new, minimally invasive treatment superior to current PDT methods.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PhotochemotherapyImmunotoxinsLung NeoplasmsHumansAnimalsMiceCetuximabPhototherapyPhotosensitizing Agents

Stichwörter der Autor:innen

drug delivery systemendosomal escapeimmunotoxinmono-l-aspartyl chlorin e6 (NPe6)photodynamic therapy

Substanzen

ImmunotoxinsCetuximabPhotosensitizing Agents

Autor:innen und Institutionen

  • Department of Thoracic Surgery, Nippon Medical School, Tokyo, Japan.
  • Research & Development Division, PhotoQ3 Inc., Tokyo, Japan.

ORCID-Profile: Takumi Sonokawa

Förderung

  • Japan Society for the Promotion of Science

Zitieren

APA

Sonokawa, T., Obi, N., Usuda, J., Sudo, Y., & Hamakubo, T. (2023). Development of a new minimally invasive phototherapy for lung cancer using antibody–toxin conjugate. Thoracic Cancer, 14(7), 645-653. https://doi.org/10.1111/1759-7714.14776

Vancouver

Sonokawa T, Obi N, Usuda J, Sudo Y, Hamakubo T. Development of a new minimally invasive phototherapy for lung cancer using antibody–toxin conjugate. Thoracic Cancer. 2023;14(7):645-653. doi:10.1111/1759-7714.14776

BibTeX
@article{Sonokawa2023,
  author = {Sonokawa, Takumi and Obi, Naoko and Usuda, Jitsuo and Sudo, Yukio and Hamakubo, Takao},
  title = {Development of a new minimally invasive phototherapy for lung cancer using antibody–toxin conjugate},
  journal = {Thoracic Cancer},
  year = {2023},
  volume = {14},
  number = {7},
  pages = {645--653},
  doi = {10.1111/1759-7714.14776}
}
Kostenlos starten →